Chevron Other Receivables increased by 6.5% to $3.52B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 8.3%, from $3.84B to $3.52B.
Significant fluctuations may indicate one-time events or changes in non-operating business activities.
This category includes miscellaneous claims for cash that are not derived from standard trade sales of pharmaceutical pr...
Varies widely based on the complexity of a company's tax structure and collaborative R&D agreements.
other_receivables| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.10B | $3.30B | $4.20B | $4.10B | $4.60B | $4.40B | $3.90B | $4.30B | $4.10B | $4.00B | $3.80B | $3.84B | $3.80B | $3.30B | $3.30B | $3.52B |
| QoQ Change | — | +6.5% | +27.3% | -2.4% | +12.2% | -4.3% | -11.4% | +10.3% | -4.7% | -2.4% | -5.0% | +0.9% | -0.9% | -13.2% | +0.0% | +6.5% |
| YoY Change | — | — | — | +32.3% | +39.4% | +4.8% | -4.9% | -6.5% | -6.8% | +2.6% | -11.6% | — | -7.3% | -17.5% | -13.2% | -8.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.